Syz Capital partner with Saturnus Capital to take controlling stake in leading German Pharmaceutical Logistics firm, SK Pharma

Syz Capital, the boutique private markets investment specialist, announced today that it has taken a controlling stake in SK Pharma Logistics, specialized in storing, handling, repackaging and distributing pharmaceutical products. Backed by the Syz Family and in close partnership with Saturnus Capital, Syz Capital is looking to grow and accelerate the expansion of this strong market leader, bringing it to new heights.
Based in Bielefeld, Germany, SK Pharma is a family-owned business servicing both European and Global pharmaceutical companies. A leader in the space, the company specializes in pharmaceutical and medical grade products, as well as cosmetics and dietary products. The company offers the entire value chain of logistics, offering its customer turnkey solutions.

The company has been growing impressively, averaging a CAGR of 28% in the last 3 years, 7x faster than the healthcare industry in Germany over the last 10 years. The firm expects further growth as the regulatory environment is becoming stricter and the underlying industry is forecasted to grow consistently over the next few years.

Marc Syz, Managing Partner of Syz Capital, says: “We believe there is a unique opportunity to help this entrepreneurial family business expand its business and footprint organically and by acquisition, consolidating the relatively fragmented sector serving global customers. With SK Pharma, we truly have found another hidden champion which offers a strong platform to drive future value creation.

“The deal also demonstrates the potential value creation we can add to our clients’ portfolios and underlines how Syz Capital is unlocking unique synergistic opportunities in the private equity and alternatives space.”

Joscha Boehm, Managing Partner of Saturnus Capital, and Philipp Schweizer, Partner of Saturnus Capital, who teamed up with Syz Capital for this transaction commented: We are excited to be closely working with the founders and the management team to further develop SK Pharma in the coming years. We consider SK Pharma to be a well-run business that is uniquely positioned to continue to grow and gain market share.

This acquisition marks another important milestone for Syz Capital in the family businesses landscape. Both Saturnus and Marc Syz will join the SK Pharma Board of Directors along the Krone family and Philippe Milliet, a former Galenica executive and industry veteran.

Stephan Krone, CEO of SK Pharma Logistics GmbH, added: “We believe Syz Capital and Saturnus Capital are ideal partners with significant experience investing in family-owned businesses to drive SK Pharma through its next growth phase and beyond, to create value for our customers and partners. They have a clear growth strategy for the future, the management team and myself are excited to partner with them and, together, build SK Pharma into a leading European player in the Pharma Logistics Industry.”